Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions
- PMID: 24291818
- DOI: 10.1039/c3mb70305c
Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions
Abstract
Tankyrases (TNKS) belong to the poly(ADP-ribose)polymerase (PARP) protein super family and play a vital role in the Wnt/β-catenin signaling pathway. TNKS is a potential target for therapeutic intervention against various cancers, heritable diseases (e.g. cherubism) and implications in the replication of herpes simplex virus (HSV). The recent discovery of the structure of TNKS with an IWR1 inhibitor has provided insight into the binding modes which are specific for the TNKS protein which will aid in the development of drugs that are specific for the TNKS protein. The current study investigates molecular interactions between the induced pocket of TNKS1 and TNKS2 with an IWR1 compound using computational approaches. Molecular docking analysis of IWR1 at the induced pocket of TNKS1 and TNKS2 was performed. The resulting protein-ligand complexes were simulated for a timescale of 100 ns. Results revealed the stable binding of IWR1 at the induced pocket of TNKS1 and TNKS2 proteins. Apart from active site amino acids, π-π stack paring interactions were also crucial for the protein-ligand binding and stability of the complex. Further, energy-optimized pharmacophore mapping was performed and the resulting pharmacophore model contained a four (TNKS1-IWR1) and five (TNKS2-IWR1) featured sites. Based on the pharmacophore models, the best inhibitors were screened from the ZINC natural product compound database and these could be used as potential drugs against TNKS1 and TNKS2.
Similar articles
-
The binding mechanism of a novel nicotinamide isostere inhibiting with TNKSs: a molecular dynamic simulation and binding free energy calculation.J Biomol Struct Dyn. 2016;34(3):517-28. doi: 10.1080/07391102.2015.1043580. Epub 2015 Dec 9. J Biomol Struct Dyn. 2016. PMID: 25933061
-
Evidence for tankyrases as antineoplastic targets in lung cancer.BMC Cancer. 2013 Apr 28;13:211. doi: 10.1186/1471-2407-13-211. BMC Cancer. 2013. PMID: 23621985 Free PMC article.
-
In silico insights on tankyrase protein: A potential target for colorectal cancer.J Biomol Struct Dyn. 2019 Sep;37(14):3637-3648. doi: 10.1080/07391102.2018.1521748. Epub 2018 Dec 8. J Biomol Struct Dyn. 2019. PMID: 30204055
-
Insights of tankyrases: A novel target for drug discovery.Eur J Med Chem. 2020 Dec 1;207:112712. doi: 10.1016/j.ejmech.2020.112712. Epub 2020 Aug 17. Eur J Med Chem. 2020. PMID: 32877803 Review.
-
Recent advances in the structure-based rational design of TNKSIs.Mol Biosyst. 2014 Nov;10(11):2783-99. doi: 10.1039/c4mb00385c. Mol Biosyst. 2014. PMID: 25211064 Review.
Cited by
-
Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology.Viruses. 2019 Jan 15;11(1):63. doi: 10.3390/v11010063. Viruses. 2019. PMID: 30650527 Free PMC article.
-
UBE2T promotes β-catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK-dependent activation.Mol Oncol. 2022 Apr;16(8):1694-1713. doi: 10.1002/1878-0261.13111. Epub 2022 Mar 16. Mol Oncol. 2022. PMID: 34614271 Free PMC article.
-
Combining pharmacophore models derived from DNA-encoded chemical libraries with structure-based exploration to predict Tankyrase 1 inhibitors.Eur J Med Chem. 2023 Jan 15;246:114980. doi: 10.1016/j.ejmech.2022.114980. Epub 2022 Dec 2. Eur J Med Chem. 2023. PMID: 36495630 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous